FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082378435> ?p ?o ?g. }

• W3082378435 endingPage "1973" @default.
• W3082378435 startingPage "1958" @default.
• W3082378435 abstract "Vascular calcification (VC) increases the future risk of cardiovascular events in uraemic patients, but effective therapies are still unavailable. Accurate identification of those at risk of developing VC using pathogenesis-based biomarkers is of particular interest and may facilitate individualized risk stratification. We aimed to uncover microRNA (miRNA)-target protein-based biomarker panels for evaluating uraemic VC probability and severity.We created a three-tiered in vitro VC model and an in vivo uraemic rat model receiving high phosphate diet to mimic uraemic VC. RNAs from the three-tiered in vitro and in vivo uraemic VC models underwent miRNA and mRNA microarray, with results screened for differentially expressed miRNAs and their target genes as biomarkers. Findings were validated in original models and additionally in an ex vivo VC model and human cells, followed by functional assays of identified miRNAs and target proteins, and tests of sera from end-stage renal disease (ESRD) and non-dialysis-dependent chronic kidney disease (CKD) patients without and with VC. Totally 122 down-regulated and 119 up-regulated miRNAs during calcification progression were identified initially; further list narrowing based on miRNA-mRNA pairing, anti-correlation, and functional enrichment left 16 and 14 differentially expressed miRNAs and mRNAs. Levels of four miRNAs (miR-10b-5p, miR-195, miR-125b-2-3p, and miR-378a-3p) were shown to decrease throughout all models tested, while one mRNA (SULF1, a potential target of miR-378a-3p) exhibited the opposite trend concurrently. Among 96 ESRD (70.8% with VC) and 59 CKD patients (61% with VC), serum miR-125b2-3p and miR-378a-3p decreased with greater VC severity, while serum SULF1 levels increased. Adding serum miR-125b-2-3p, miR-378a-3p, and SULF1 into regression models for VC substantially improved performance compared to using clinical variables alone.Using a translational approach, we discovered a novel panel of biomarkers for gauging the probability/severity of uraemic VC based on miRNAs/target proteins, which improved the diagnostic accuracy." @default.
• W3082378435 created "2020-09-08" @default.
• W3082378435 creator A5010570183 @default.
• W3082378435 creator A5048127662 @default.
• W3082378435 creator A5048386356 @default.
• W3082378435 creator A5055169727 @default.
• W3082378435 creator A5058699238 @default.
• W3082378435 date "2020-08-31" @default.
• W3082378435 modified "2023-10-17" @default.
• W3082378435 title "A combined microRNA and target protein-based panel for predicting the probability and severity of uraemic vascular calcification: a translational study" @default.
• W3082378435 cites W1516144385 @default.
• W3082378435 cites W1532809508 @default.
• W3082378435 cites W1787884960 @default.
• W3082378435 cites W1965532883 @default.
• W3082378435 cites W1978456616 @default.
• W3082378435 cites W1981999912 @default.
• W3082378435 cites W2011530250 @default.
• W3082378435 cites W2018242510 @default.
• W3082378435 cites W2020150964 @default.
• W3082378435 cites W2049031611 @default.
• W3082378435 cites W2049291797 @default.
• W3082378435 cites W2056412036 @default.
• W3082378435 cites W2057807965 @default.
• W3082378435 cites W2072968852 @default.
• W3082378435 cites W2077271670 @default.
• W3082378435 cites W2084413241 @default.
• W3082378435 cites W2104516575 @default.
• W3082378435 cites W2104592429 @default.
• W3082378435 cites W2119218375 @default.
• W3082378435 cites W2127873963 @default.
• W3082378435 cites W2313336646 @default.
• W3082378435 cites W2506033590 @default.
• W3082378435 cites W2539472999 @default.
• W3082378435 cites W2549218357 @default.
• W3082378435 cites W2551772736 @default.
• W3082378435 cites W2553016371 @default.
• W3082378435 cites W2615964728 @default.
• W3082378435 cites W2616194894 @default.
• W3082378435 cites W2621068092 @default.
• W3082378435 cites W2621744922 @default.
• W3082378435 cites W2757254843 @default.
• W3082378435 cites W2761931108 @default.
• W3082378435 cites W2762359296 @default.
• W3082378435 cites W2799394337 @default.
• W3082378435 cites W2800599602 @default.
• W3082378435 cites W2802265270 @default.
• W3082378435 cites W2804641693 @default.
• W3082378435 cites W2890673904 @default.
• W3082378435 cites W2894933901 @default.
• W3082378435 cites W2898030699 @default.
• W3082378435 cites W2909788535 @default.
• W3082378435 cites W2921632205 @default.
• W3082378435 cites W2925074648 @default.
• W3082378435 cites W2927936384 @default.
• W3082378435 cites W2942265404 @default.
• W3082378435 cites W2946274893 @default.
• W3082378435 cites W2970532676 @default.
• W3082378435 cites W4210573269 @default.
• W3082378435 doi "https://doi.org/10.1093/cvr/cvaa255" @default.
• W3082378435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32866261" @default.
• W3082378435 hasPublicationYear "2020" @default.
• W3082378435 type Work @default.
• W3082378435 sameAs 3082378435 @default.
• W3082378435 citedByCount "21" @default.
• W3082378435 countsByYear W30823784352020 @default.
• W3082378435 countsByYear W30823784352021 @default.
• W3082378435 countsByYear W30823784352022 @default.
• W3082378435 countsByYear W30823784352023 @default.
• W3082378435 crossrefType "journal-article" @default.
• W3082378435 hasAuthorship W3082378435A5010570183 @default.
• W3082378435 hasAuthorship W3082378435A5048127662 @default.
• W3082378435 hasAuthorship W3082378435A5048386356 @default.
• W3082378435 hasAuthorship W3082378435A5055169727 @default.
• W3082378435 hasAuthorship W3082378435A5058699238 @default.
• W3082378435 hasBestOaLocation W30823784351 @default.
• W3082378435 hasConcept C104317684 @default.
• W3082378435 hasConcept C126322002 @default.
• W3082378435 hasConcept C145059251 @default.
• W3082378435 hasConcept C150194340 @default.
• W3082378435 hasConcept C186836561 @default.
• W3082378435 hasConcept C207001950 @default.
• W3082378435 hasConcept C2778653478 @default.
• W3082378435 hasConcept C2780942790 @default.
• W3082378435 hasConcept C2781197716 @default.
• W3082378435 hasConcept C54355233 @default.
• W3082378435 hasConcept C60644358 @default.
• W3082378435 hasConcept C71924100 @default.
• W3082378435 hasConcept C86803240 @default.
• W3082378435 hasConceptScore W3082378435C104317684 @default.
• W3082378435 hasConceptScore W3082378435C126322002 @default.
• W3082378435 hasConceptScore W3082378435C145059251 @default.
• W3082378435 hasConceptScore W3082378435C150194340 @default.
• W3082378435 hasConceptScore W3082378435C186836561 @default.
• W3082378435 hasConceptScore W3082378435C207001950 @default.
• W3082378435 hasConceptScore W3082378435C2778653478 @default.
• W3082378435 hasConceptScore W3082378435C2780942790 @default.
• W3082378435 hasConceptScore W3082378435C2781197716 @default.
• W3082378435 hasConceptScore W3082378435C54355233 @default.

• next